October 11, 2024Balchem Announces Conference Call for Third Quarter 2024 Financial Results
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2024 financial results.
July 26, 2024Balchem Corporation Reports Second Quarter 2024 Financial Results
Ted Harris, Chairman, President and CEO said, “We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth.”
July 12, 2024Balchem Announces Conference Call for Second Quarter 2024 Financial Results
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2024 financial results.
May 3, 2024Balchem Corporation Reports First Quarter 2024 Financial Results
Ted Harris, Chairman, President and CEO of Balchem said, “The first quarter was a very good start to the year for Balchem. We delivered record net sales, adjusted EBITDA, and net earnings, as well as solid first quarter cash flows, despite the continued challenging environment in parts of our portfolio.”
April 22, 2024Balchem Releases 2023 Sustainability Report
Balchem Corporation today released its 2023 Sustainability Report, which captures the Company’s commitment to managing our Environmental, Social and Governance (ESG) performance.
April 19, 2024Balchem Announces Conference Call for First Quarter 2024 Financial Results
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, May 3, 2024, at 11:00 AM Eastern Time (ET) to review 1st Quarter 2024 financial results.
February 16, 2024Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Ted Harris, Chairman, CEO, and President of Balchem said, “Our full year 2023 results highlight the resilience of our business model in a challenging and volatile market environment.”
February 2, 2024Balchem Announces Conference Call for Fourth Quarter 2023 Financial Results
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, February 16, 2024, at 11:00 AM Eastern Time (ET) to review 4th Quarter 2023 financial results.
December 15, 2023Balchem Named on Newsweek’s 2024 List of America’s Most Responsible Companies
Balchem named one of America’s Most Responsible Companies by Newsweek magazine for the fourth consecutive year.
December 5, 2023Balchem Announces Dividend
Ted Harris, Balchem’s Chairman, President, and CEO, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.”
October 27, 2023Balchem Announces Third Quarter 2023 Financial Results
Ted Harris, Chairman, President, and CEO of Balchem said, “I am very pleased with our third quarter performance. We delivered record Adjusted EBITDA as a result of improved mix, manufacturing efficiencies, and easing inflationary pressures.”
October 13, 2023Balchem Announces Conference Call for Third Quarter 2023 Financial Results
Join Ted Harris, Chairman of the Board, President and CEO and Martin Bengtsson, CFO on Friday, October 27, 2023, at 11:00 AM Eastern Time (ET) to review third quarter financial results.
July 28, 2023Balchem Announces Second Quarter 2023 Financial Results
Ted Harris, Chairman, President, and CEO of Balchem said, “We delivered solid second quarter financials, and I am particularly pleased with our strong profitability and margin performance as we move forward from the highly inflationary period we experienced over the last two years.”
July 14, 2023Balchem Announces Conference Call for Second Quarter 2023 Financial Results
Join Ted Harris, Chairman of the Board, President and CEO and Martin Bengtsson, CFO on Friday, July 28, 2023, at 11:00 AM Eastern Time (ET) to review second quarter financial results.
April 28, 2023Balchem Announces First Quarter 2023 Financial Results
Ted Harris, Chairman, President, and CEO of Balchem said, “We delivered solid first quarter financial performance with sales and adjusted EBITDA growth both compared to prior year’s very strong results, and sequentially compared to the fourth quarter of 2022.
April 26, 2023Balchem Releases 2022 Sustainability Report
Balchem Corporation today released its 2022 Sustainability Report, which captures the Company’s commitment to managing our Environmental, Social and Governance (ESG) performance.
April 14, 2023Balchem Announces Conference Call for First Quarter 2023 Financial Results
Join Ted Harris, Chairman of the Board, President and CEO and Martin Bengtsson, CFO on Friday, April 28, 2023, at 11:00 AM Eastern Time (ET) to review first quarter financial results.
February 24, 2023Balchem Announces Fourth Quarter 2022 Financial Results
Ted Harris, Chairman, CEO, and President of Balchem said, “The fourth quarter capped off another strong year for Balchem.  For the full year, we achieved record sales of $942 million dollars, growing almost 18 percent year over year, with record sales in all three of our business segments.”
February 10, 2023Balchem Announces Conference Call for Fourth Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 24th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2022 results.
January 6, 2023Balchem Corporation Named on Newsweek’s 2023 List of America’s Most Responsible Companies
Balchem named one of America’s Most Responsible Companies by Newsweek magazine for the third consecutive year.
December 6, 2022Balchem Announces Dividend
Ted Harris, Balchem’s Chairman, President, and CEO, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.”
November 4, 2022Balchem Corporation Reports Third Quarter 2022 Financial Results
Ted Harris, Chairman, President and CEO of Balchem said, “The third quarter of 2022 was another solid growth quarter for Balchem as we delivered both sales and earnings growth year over year in an increasingly challenging macro-economic environment.”
October 21, 2022Balchem Announces Conference Call for Third Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, November 4th at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2022 results.
August 30, 2022Balchem Corporation Acquires Bergstrom Nutrition
Balchem Corporation is excited to announce the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington.
July 29, 2022Balchem Corporation Reports Second Quarter 2022 Financial Results
Ted Harris, Chairman, CEO, and President of Balchem said, “The second quarter of 2022 was another excellent quarter for Balchem. We delivered very strong financial results with record sales and adjusted EBITDA in what remains a very difficult macro-economic and geo-political environment.”
July 15, 2022Balchem Announces Conference Call for Second Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, July 29th at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2022 results.
June 21, 2022Balchem Corporation Completes Acquisition of Kappa Bioscience AS
We are excited to announce that we completed our acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
June 14, 2022Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS
Balchem has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
May 18, 2022VitaCholine® Enhances Maternal DHA Status (Cornell Study)
A paper just published in The American Journal of Clinical Nutrition (AJCN) highlights the unique role choline plays in enhancing docosahexaenoic acid (DHA) status during pregnancy.
April 29, 2022Balchem Corporation Reports First Quarter 2022 Financial Results
Ted Harris, Chairman, CEO, and President of Balchem said, “We are very pleased to have continued the strong momentum from 2021 into 2022. In the first quarter of 2022 we delivered all-time record sales, adjusted net earnings, and adjusted EBITDA in a very difficult macro-economic and geo-political environment.”
April 22, 2022Balchem Releases 2021 Sustainability Report
Balchem Corporation today released its 2021 Sustainability Report, which captures the Company’s commitment to managing our Environmental, Social and Governance (ESG) performance.
April 15, 2022Balchem Announces Conference Call for First Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 29th at 11:00 AM Eastern Time (ET) to review 1st Quarter 2022 results.
January 18, 2022Balchem Corporation Named on Newsweek’s 2022 List of America’s Most Responsible Companies
Balchem named one of America’s Most Responsible Companies by Newsweek magazine for the second consecutive year.
December 16, 2021Balchem Announces Dividend
Ted Harris, Balchem’s CEO and President, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.”
December 17, 2020Balchem Corporation Announces Dividend
Balchem declares a dividend on its shares of common stock equal to $0.58 per share which represents the eleventh consecutive increase.
December 18, 20192019 Dividend Press Release
May 2, 2019Balchem Corporation Signs Definitive Agreement to Acquire Chemogas NV
Balchem Corporation (NASDAQ: BCPC) today announced that it has signed a definitive agreement to acquire Chemogas NV, a privately held specialty gases company, headquartered in Grimbergen, Belgium.